With NeoBreathe, pfmmedical presents another device for the neonatology sector
05/12/2025
The Cologne-based medical technology company pfmmedical has developed, together with users, the NeoBreathe non-invasive respiration valve for the immediate care of premature and newborn babies receiving CPAP therapy. Dr. Bianca Haase, Head of the Paediatric Department, Kreiskliniken Reutlingen, will present the device at stand no. 029 at the annual conference of the Society for Neonatology and Paediatric Intensive Care Medicine (Gesellschaft für Neonatologie und Pädiatrische Intensivmedizin – GNPI). Thus, pfmmedical continues to strengthen its presence in the neonatology market.
“NeoBreathe is a real innovation”, emphasises Haase. “In critical moments when every second counts, it provides doctors and nurses with a quick and safe solution.” The intuitive respiration valve is quickly ready for use and helps to reduce additional respiratory work as much as possible.1 “With the marketing authorisation for this device, we are very pleased to have reached an important milestone on our journey to pfmmedical for the little ones,” summarises Ole Kopitz, Vice President Sales & Marketing. “Our aim”, continues Kopitz, “is to continuously improve care for premature and newborn babies so that they can develop optimally thanks to the best possible medical care. With NeoBreathe, we are bringing to market a real jump-start for the little ones.”
The NeoBreathe developed by pfmmedical is manufactured in our production facility pfm medical mepro gmbh in Saarland.
For more information about NeoBreathe, please click here.
Visit us at the conference
- 51st Conference of the Society for NeonatologyNeonatology is the special branch of pediatrics concerned with the typical disorders of the newborn and treatment of premature infants. and Paediatric Intensive Care Medicine (GNPI)
- Music and Congress Hall, Lübeck
- Meet the Expert “Jump-start“
- Friday, 23 May 2025, at 9:30 and 15:00
- Stand no. 029
Source
1. Sterzik et al., In-Vitro-Studie zur Ermittlung der zusätzlichen Atemarbeit von 16 CPAP-Geräten; 2024